Clinical Trial Update: 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of 5-fluorouracil, bevacizumab, radiation, followed by modified FOLFOX6 and bevacizumab in stage II/III rectal cancer has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Modified FOLFOX6 (FOLFOX6 regimen)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Rectal Cancer, Cancer of the Rectum | Phase 2 | Status: COMPLETED | Results posted: 2013-05-14